We revealed that plasma Aβ42, Aβ40, p-tau181, and NfL levels were significantly correlated with their CSF counterparts in participants with AD and healthy controls, indicating that plasma concentrations of these biomarkers may reflect CSF changes. This evidence concerns the gene NEFL and Alzheimer disease.